载体蛋白质大小对发生免疫性和抗体亲和力在小鼠中的影响
Maksim A Burkin1, Valeria A Litvinova2, Alexander S Tikhomirov2
1I. Mechnikov Research Institute for Vaccines and Sera, Moscow 105064, Russia.
Bioconjugate chemistry
|December 12, 2025
概括
较大的蛋白质载体显著增强了触觉免疫性和抗体亲和力. 这一发现表明,使用更大的载体可以改善疫苗开发,特别是对于免疫性较差的 hapten.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
- 生物结合化学 生物结合化学
背景情况:
- 发生免疫性和抗发生抗体亲和力是疫苗疗效的关键.
- 以前的研究比较了蛋白质载体,但没有明确载体大小的影响.
- 影响免疫反应的因素包括触觉和载体特征.
研究的目的:
- 为了研究载体蛋白质大小对哈普免疫性的影响.
- 评估载体大小对抗甲抗体亲和力的影响.
- 评估载体大小作为一种提高对 haptens 的免疫反应的策略.
主要方法:
- 合成了新型的甲尼达衍生物作为模型的 haptens.
- 使用牛血清专蛋白 (BSA) 的单,二,三和四分体制造的基和基.
- 在小鼠模型中,在不同的载体大小中确保了等效的 hapten 负载和呈现.
主要成果:
- BSA二聚和较大的合物显著增加了抗哈抗体标位.
- 较大的载体加速了抗体的产生和成熟.
- 增加载体大小增强了 hapten 免疫性和抗体亲和力.
结论:
- 扩大的蛋白质载体提高了的免疫性和抗抗体亲和力.
- 较大的载体代表了开发候选疫苗的有希望的战略.
- 这种方法对免疫性较弱的 hapten 特别有益.
相关概念视频
Antigens Involved in Adaptive Immunity
1.2K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.2K
Affinity and Avidity
38.4K
Overview
38.4K
Factors Affecting Protein-Drug Binding: Drug-Related Factors
434
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
434


